Scarica l'app Stockscreener
0.6751
0.72%
-0.0049
Dopo l'orario di chiusura:
.68
0.0049
+0.73%
Precedente Chiudi:
$0.68
Aprire:
$0.68
Volume 24 ore:
102.15K
Relative Volume:
1.56
Capitalizzazione di mercato:
$11.75M
Reddito:
$52.58M
Utile/perdita netta:
$-3.28M
Rapporto P/E:
-3.5034
EPS:
-0.1927
Flusso di cassa netto:
$-2.53M
1 W Prestazione:
-3.65%
1M Prestazione:
-19.81%
6M Prestazione:
-49.62%
1 anno Prestazione:
-48.92%
Intervallo 1D:
$0.66
$0.6899
Intervallo di 1 settimana:
$0.66
$0.7159
Portata 52W:
$0.66
$1.6481
Iridex Corp Stock (IRIX) Company Profile
Nome
Iridex Corp
Settore
Industria
Telefono
(650) 940-4700
Indirizzo
1212 TERRA BELLA AVE, MOUNTAIN VIEW, CA
Compare IRIX vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IRIX
Iridex Corp
|
0.6751 | 11.84M | 52.58M | -3.28M | -2.53M | -0.1927 |
ABT
Abbott Laboratories
|
103.36 | 182.09B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
91.62 | 117.54B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
270.01 | 105.63B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.10 | 65.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.77 | 49.67B | 6.30B | 1.07B | 1.09B | 1.8406 |
Iridex Corp Stock (IRIX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2017-11-03 | Ripresa | ROTH Capital | Buy |
| 2016-12-21 | Iniziato | ROTH Capital | Buy |
| 2016-01-26 | Iniziato | Singular Research | Buy |
| 2007-01-03 | Iniziato | First Albany | Buy |
Iridex Corp Borsa (IRIX) Ultime notizie
CFO now holds 175,052 shares after Iridex Corp (IRIX) stock buy - Stock Titan
IRIDEX Received Notice of Noncompliance - TradingView
IRIDEX (NASDAQ:IRIX): What Is Driving Penny Stock Attention? - Kalkine Media
IRIDEX (NASDAQ:IRIX): Is Clinical Demand Building Momentum? - Kalkine Media
IRIDEX Q2 Loss Widens Y/Y as Retina Weakness Weighs, Stock Down 15% - Yahoo Finance
IRIDEX (IRIX) CFO adds 6,668 shares in open-market buys - Stock Titan
IRIDEX Q2 Revenue Falls 7% as Retina Weakness Offsets Glaucoma Growth - Minichart
IRIDEX Corp (IRIX) (Q2 2026) Earnings Call Highlights: Cyclo-G6 - GuruFocus
IRIX Looks 45.3% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
Earnings call transcript: IRIDEX misses Q2 2026 estimates as cash flow turns positive - Investing.com South Africa
IRIDEX Corporation Q2 2026 Earnings Call Summary - Yahoo Finance
Is IRIDEX Corp (IRIX) Positioned for Growth After Q2 Earnings Mi - GuruFocus
Form 8K IRIDEX Corporation For: 18 August By Investing.com - Investing.com Canada
Full Transcript: Iridex Q2 2026 Earnings Call - Benzinga
IRIDEX Corp reports results for the quarter ended June 30Earnings Summary - TradingView
IRIDEX CORP Q2 2026: Revenue $12.6M, EPS $(0.07) — 10-Q Summary - TradingView
IRIDEX (IRIX) glaucoma sales rise as retina revenue falls - Stock Titan
IRIDEX earnings missed by $0.05, revenue fell short of estimates - Investing.com
Iridex Reports Q2 2026 Revenue $12.6M, Net Loss $1.3M; Cyclo G6 Probe Growth Boosts Glaucoma Sales - TradingView
Iridex falls short on Q2 revenue and earnings expectations - Investing.com
Iridex falls short on Q2 revenue and earnings expectations By Investing.com - Investing.com Australia
IRIDEX ($IRIX) Releases Q2 2026 Earnings - Quiver Quantitative
Iridex Latest Results: FY26 sales guidance affirmed at $51M-$53M, below est - scanx.trade
Iridex Q2 revenue misses estimate as loss widens to $0.07 - scanx.trade
Iridex: Q2 Earnings Snapshot - marketscreener.com
Iridex Reports Second Quarter 2026 Financial Results - GlobeNewswire
Iridex (NASDAQ:IRIX): Why Is Ophthalmic Systems And Procedure Activity in Focus Today? - Kalkine Media
IRIDEX (IRIX) Earnings Call Q2 2026: G6-Wachstum und positiver Cashflow - TradingKey
IRIX|IRIDEX Corp|Price:0.880|Chg%:+0.024 - TradingKey
IRIDEX Corp (IRIX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
IRIDEX Corp (IRIX) Stock News Today - TradingKey
Iridex schedules Q2 business update after Aug. 18 close - Stock Titan
Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026 - Barchart.com
IRIX Faces Continued Pressure Near Key Support Levels – IRIDEX Corporation (IRIX) at $0.86Wyckoff Distribution - dars.gov.et
IRIDEX Corp (IRIX) Institutional Confidence - TradingKey
IRIX|IRIDEX Corp|Price:0.889|Chg%:-0.002 - TradingKey
IRIDEX Corp (IRIX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
IRIDEX Corp (IRIX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
IRIDEX Corp (IRIX) Cash Flow - TradingKey
IRIDEX Corp (IRIX) Valuation: PE, PB & Fair Value Analysis - TradingKey
IRIX|IRIDEX Corp|Price:0.783|Chg%:-0.147 - TradingKey
IRIDEX Corp (IRIX) Income Statement - TradingKey
IRIDEX Corp (IRIX) Earnings Date & Reports & Earnings News - TradingKey
IRIDEX Corp (IRIX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
IRIDEX Corp (IRIX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
IRIDEX Corp (IRIX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
IRIX|IRIDEX Corp|Price:0.930|Chg%:+0.050 - TradingKey
Iridex expands EyeProGPO offering with EndoProbe handpieces - Investing.com
More Than 4,300 EyeProGPO Members Gain Preferred EndoProbe Pricing - Stock Titan
Iridex Board Warns of Legal Risks in Stealth Proxy Campaign by Major Shareholder Novel Inspiration - Minichart
Form 4 IRIDEX Corporation For: 14 July By Investing.com - Investing.com Nigeria
Iridex Corp Azioni (IRIX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.29%
0.75%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):